LNTH: Lantheus Holdings, Inc.
Performance
LNTH +97.79%
Watchlist
Select an item
Summary
LNTH at a glance
LNTH returned +97.79% over the past year and +28.33% a year over five years. Its worst drop in that year was -12.17%, smaller than 96% of stocks on Redstone, and its Sharpe ratio of 2.26 beats 99% of stocks on Redstone. It pays no dividends.
Current Drawdown
-8.95%
Rolling Volatility
3.99%
Actions
Metrics
Risk Indicators
Alpha64.79%
Beta0.48x
Sharpe2.26
Sortino4.08
Omega1.55
Calmar8.03
Martin11.44
Profile
About LNTH
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue.
- Sector
- Health Care
- Industry
- In Vitro & in Vivo Diagnostic Substances
- Market cap
- $6.6B
- Listed
- Jun 2015
- Employees
- 1,193
- Headquarters
- North Billerica, MA
- Website
- lantheus.com
Comparisons